On-Farm Antimicrobial Data Dashboards
Several important bacterial diseases continue to present problems to the health and welfare of U.S. chickens and turkeys. The ability to reduce the use of antimicrobials in U.S. poultry will be predicated on our ability to reduce the incidence of these key diseases.
- Necrotic enteritis, colibacillosis, and gangrenous (clostridial) dermatitis are some of the most important diseases of chickens that require antimicrobial therapy. Many of the respiratory diseases affecting chickens are caused by E. coli.
- Clostridial dermatitis, bacterial enteritis, and colibacillosis are some of the most important diseases of turkeys that require antimicrobial therapy.
- Avian metapneumovirus has caused severe morbidity and mortality in turkey and chicken flocks. Infection with this virus can lead to an increased incidence of secondary bacterial infections, which has led to increases in antimicrobial use, when effective.
Singer, R. S., Schrag, N. F. D., Porter, L. J. (2025). On-farm antimicrobial usage data in commercial poultry production in the United States, 2013-2024. Available at: https://mindwalkconsultinggroup.com/.
- Necrotic enteritis
- Clostridial dermatitis
- Avian metapneumovirus
Singer, R. S., Schrag, N. F. D., Porter, L. J. (2025). On-farm antimicrobial usage data in commercial poultry production in the United States, 2013-2024. Available at: https://mindwalkconsultinggroup.com/.
Companies participated in this study voluntarily and represented a large percentage of the overall U.S. production.
- The datasets represent approximately 87% of broiler chicken, 73% of turkey, and 47% of eggs produced annually, based on USDA:National Agricultural Statistics Service published numbers
- The broiler data for 2024 include information on approximately 8,774,000,000 chicks placed, 8,233,000,000 chickens slaughtered, and 54,983,000,000 pounds liveweight produced
- The turkey data for 2024 include information on more than 167,000,000 poults placed, 143,000,000 turkeys slaughtered, and 4,628,000,000 pounds liveweight produced
- The egg layer data for 2024 include information on approximately 145,000,000 average hens in lay and 366,300,000 dozen eggs produced
Singer, R. S., Schrag, N. F. D., Porter, L. J. (2025). On-farm antimicrobial usage data in commercial poultry production in the United States, 2013-2024. Available at: https://mindwalkconsultinggroup.com/.
Acknowledgments
This project is funded with multiple annual grants from the U.S. Poultry & Egg Association. The project was also partly supported from 2016 to 2023 under a cooperative agreement with the U.S. Food and Drug Administration (U01FD005878). Beginning in September 2024, a new cooperative agreement between FDA-CVM and Mindwalk Consulting Group (U01FD008419) was initiated. This ongoing monitoring program would not be possible without the voluntary participation of layer, broiler chicken and turkey companies of the U.S. as well as support from the National Chicken Council, National Turkey Federation, United Egg Producers.
USPOULTRY also publishes an infographic report on antibiotic use in U.S. poultry production, based on data collected through this project.